Cochrane Reviews: PsychiatryMatters.MD - New generation antipsychotics for first episode schizophrenia
The results of this review are inconclusive. Whether the use of new generation antipsychotics really makes the treatment less off putting and enhances long-term compliance is unclear. Pragmatic, well-designed and reported long-term trials would be useful to answer this question.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario